Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Cannabis May Be Sabotaging Your Sleep Without You Even Knowing It, Study Finds (opens in a new tab)

scitechdaily.com · 2026-10-22

Short answerEvidenceSource

Short answer

Supported

Supported.

The story matches what the study reports.

  • 5 supported

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Supported

Every claim holds up. All five claims match what the study reports.

  • 5 supported
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5SupportedNearly 35 years of observational data link greater lifetime cannabis use to poorer sleep in middle age, challenging its reputation as a sleep aid.View evidenceHide evidence

As statedNearly 35 years; poorer sleep in middle age

Why this verdict

The abstract-profile evidence supports an observational 35-year CARDIA analysis in which greater cumulative cannabis exposure, measured in cannabis-years, was associated with poorer objective midlife sleep metrics on wrist actigraphy. The paper profile also notes cannabis is often promoted as a sleep aid, so the headline framing that the findings challenge that reputation is consistent and does not assert causality.

1

Study evidence

Each additional cannabis-year was associated with higher odds of low sleep percentage on 7-day actigraphy.OR 1.10 (95% CI 1.06–1.14) per cannabis-year

“This cohort study analyzed data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, including 35 years of follow-up through the year-35 examination (conducted in 2020 to 2022), and the CARDIA Year-35 Sleep Ancillary Study.”
Claim 2 of 5SupportedA new Northwestern Medicine study linked recent cannabis use to a greater likelihood of sleeping more than eight hours and to more disrupted nights measured by wrist-worn monitors.View evidenceHide evidence

As statedMore than eight hours; greater likelihood

Why this verdict

The profile reports that recent past-30-day cannabis use was associated with worse objective sleep on 7-day wrist actigraphy, including higher odds of high fragmentation, prolonged WASO, low sleep percentage, and long sleep duration greater than 8 hours versus optimal sleep.

1

Study evidence

Recent (past-30-day) cannabis use was associated with higher odds of low sleep percentage measured by 7-day actigraphy compared with former/never users.

“recent cannabis use (defined as past 30-day use vs former use and never use)”
Claim 3 of 5SupportedThe fragmented sleep and longer stretches awake recorded by wrist-worn monitors were not reflected in participants' own sleep ratings, suggesting people may not notice the disturbances.View evidenceHide evidence

Why this verdict

The profile supports the contrast between objective actigraphy disruptions and null subjective sleep findings: cumulative and recent use were associated with objective fragmentation/WASO-type outcomes, while cannabis use was not associated with subjective sleep quality measured by PSQI. The added interpretation that participants may not notice the disturbances is hedged and reasonably follows from the objective/subjective mismatch, though it was not directly tested as awareness.

1

Study evidence

Each additional cannabis-year was associated with higher odds of low sleep percentage on 7-day actigraphy.OR 1.10 (95% CI 1.06–1.14) per cannabis-year

“This cohort study analyzed data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, including 35 years of follow-up through the year-35 examination (conducted in 2020 to 2022), and the CARDIA Year-35 Sleep Ancillary Study.”
2

Study evidence

Recent (past-30-day) cannabis use was associated with higher odds of low sleep percentage measured by 7-day actigraphy compared with former/never users.

“recent cannabis use (defined as past 30-day use vs former use and never use)”
Claim 4 of 5SupportedGreater cumulative cannabis use was associated with lower sleep efficiency, more fragmented sleep, and more time awake after initially falling asleep.View evidenceHide evidence

Why this verdict

The profile states that each additional cannabis-year was associated with higher odds of low sleep percentage, high sleep fragmentation, and prolonged wake after sleep onset on 7-day actigraphy after multivariable adjustment. The story’s 'lower sleep efficiency' corresponds to the paper-profile's low sleep percentage outcome.

1

Study evidence

Each additional cannabis-year was associated with higher odds of low sleep percentage on 7-day actigraphy.OR 1.10 (95% CI 1.06–1.14) per cannabis-year

“This cohort study analyzed data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, including 35 years of follow-up through the year-35 examination (conducted in 2020 to 2022), and the CARDIA Year-35 Sleep Ancillary Study.”
Claim 5 of 5SupportedThe study was not designed to determine whether cannabis directly causes sleep problems, so the findings establish an association rather than a causal effect.View evidenceHide evidence

Why this verdict

The supplied profile classifies the analyses as observational cohort analyses. It also lists causal inference limitations and residual confounding concerns, supporting the story’s statement that the study establishes associations rather than direct causal effects.

1

Study evidence

Each additional cannabis-year was associated with higher odds of low sleep percentage on 7-day actigraphy.OR 1.10 (95% CI 1.06–1.14) per cannabis-year

“This cohort study analyzed data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, including 35 years of follow-up through the year-35 examination (conducted in 2020 to 2022), and the CARDIA Year-35 Sleep Ancillary Study.”
2

Study evidence

Recent (past-30-day) cannabis use was associated with higher odds of low sleep percentage measured by 7-day actigraphy compared with former/never users.

“recent cannabis use (defined as past 30-day use vs former use and never use)”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Exposure measurement may be subject to misclassification because recent use and exposure histories rely on reported cannabis use; abstract-depth evidence also does not provide all covariate or subjective-outcome effect-estimate details.

    The story mentions several caveats, but it does not specifically note potential self-report exposure misclassification or the limited abstract-level detail on covariates and PSQI effect estimates.

    From Cohort study (CARDIA Year-35 Sleep Ancillary)

6 things the story did carry across
  • Cumulative cannabis exposure across 35 years in CARDIA was associated with poorer objective sleep in middle age, including low sleep percentage, higher fragmentation, and prolonged WASO.
  • Recent past-30-day cannabis use was associated with worse objective sleep, including long sleep duration greater than 8 hours and disrupted actigraphy metrics.
  • Cannabis use was not associated with subjective sleep quality measured by PSQI, despite objective actigraphy associations.
  • The evidence is observational, so causal inference is limited and residual confounding cannot be excluded.
  • Objective sleep was assessed using 7-day wrist actigraphy, while subjective sleep was measured with PSQI; these measurement approaches capture different aspects of sleep.
  • Exposure definitions mattered: cumulative use was measured in cannabis-years, and recent use was defined as past-30-day use versus former/never use.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoAssess whether cumulative cannabis exposure from young adulthood through midlife (cannabis-years across 35 years in CARDIA) is associated with objective sleep outcomes in middle age (actigraphy-derived sleep duration category, sleep percentage, fragmentation, WASO).Prospective cohort (CARDIA Year-35 Sleep Ancillary Study)Expand

In plain English

In CARDIA participants at Year-35, greater cumulative cannabis exposure (measured in cannabis-years across 35 years) was associated with poorer objectively measured sleep on 7-day wrist actigraphy (higher odds of low sleep percentage, greater sleep fragmentation, and prolonged WASO) after multivariable adjustment.

Key findings

  • Each additional cannabis-year was associated with higher odds of low sleep percentage on 7-day actigraphy.OR 1.10 (95% CI 1.06–1.14) per cannabis-year
  • Each additional cannabis-year was associated with higher odds of high sleep fragmentation (index in highest quartile) on actigraphy.OR 1.04 (95% CI 1.01–1.08) per cannabis-year
“This cohort study analyzed data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, including 35 years of follow-up through the year-35 examination (conducted in 2020 to 2022), and the CARDIA Year-35 Sleep Ancillary Study.”
2human in vivoAssess whether recent cannabis use (past-30-day use vs former/never) is associated with objective sleep outcomes in middle age (actigraphy-derived sleep duration category, sleep percentage, fragmentation, WASO).Cohort study (observational)Expand

In plain English

In the CARDIA Year-35 Sleep Ancillary Study (2020–2022), recent cannabis use (past-30-day use vs former/never) was associated with worse objective sleep on 7-day wrist actigraphy at midlife: recent users had higher odds of low sleep percentage, high sleep fragmentation, prolonged wake after sleep onset (WASO), and long (vs optimal) sleep duration. Specific adjusted odds reported in the abstract include prolonged WASO (vs never use OR 3.23, 95% CI 1.44–7.27) and long sleep duration (vs never use OR 4.60, 95% CI 1.81–11.70). No association was observed with subjective sleep quality (PSQI).

Key findings

  • Recent (past-30-day) cannabis use was associated with higher odds of low sleep percentage measured by 7-day actigraphy compared with former/never users.
  • Recent cannabis use was associated with higher odds of high sleep fragmentation (highest quartile) on actigraphy compared with former/never users.
“recent cannabis use (defined as past 30-day use vs former use and never use)”
3human in vivoAssess whether cumulative and/or recent cannabis use is associated with subjective sleep quality in middle age (PSQI score / poor sleep quality).Cohort study (CARDIA Year-35 Sleep Ancillary)Expand

In plain English

In the CARDIA cohort Year-35 Sleep Ancillary study (n=1,128 with subjective sleep data), cumulative cannabis exposure (cannabis-years) and recent cannabis use (past 30-day vs former/never) were examined for association with self-reported sleep quality measured by the Pittsburgh Sleep Quality Index (PSQI). After multivariable adjustment, the authors report no association between cannabis use and subjective sleep quality (PSQI score or classification of poor sleep quality, PSQI >5).

Key findings

  • No multivariable-adjusted association was reported between cumulative cannabis exposure or recent past-30-day cannabis use and subjective sleep quality measured by the PSQI (PSQI score and poor sleep quality defined as PSQI >5).
“subjective sleep was assessed with the Pittsburgh Sleep Quality Index (PSQI)”
What this piece can’t prove
  • Observational cohort analysis—causal inference is limited and potential residual confounding remains.
  • Subjective outcome: PSQI is self-reported and may not capture the same aspects of sleep as objective measures.
  • Abstract does not list covariates included in the multivariable models or provide numeric effect estimates for PSQI outcomes.
  • Recent use classified as past 30-day use; exposure and outcome measurements rely on self-report and may be subject to misclassification.
Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 15 candidate papers

And 9 more candidates considered.